- Therapy of Mild-to-Moderate Psoriasis Introduction
- General Approach to Psoriasis Treatment
- The Koo-Menter Psoriasis Instruments for Identifying Candidate Patients For Systemic Therapy
- General Guidelines for Administration of Topical Agents in the Treatment of Mild-to-Moderate Psoriasis
- Topical Corticosteroids
- Vitamin D3 Analogs
- Fixed-Dose Corticosteroid / Calcipotriene Combination Therapy
- Tazarotene
- Topical Calcineurin Inhibitors
- Treatment of Mild-to-Moderate Psoriasis with Coal Tar, Anthralin, Salicyclic Acid, and Lactic Acid
- Phototherapy and Laser for the Treatment of Mild-to-Moderate Psoriasis
- Combination Therapy
- Topical Sequential Therapy of Psoriasis
- New Developments in Treatment of Mild-to-Moderate Psoriasis Therapy
- Palmoplantar Psoriasis
- Scalp Psoriasis
- Inverse Psoriasis
- Psoriasis of the Nails
- John Y.M. Koo, Director of the University of California at San Francisco (UCSF) Medical Center Psoriasis and Skin Treatment Center, and Professor of Dermatology and Vice- Chairman of Department of Dermatology, UCSF Medical Center, San Francisco, California, USA. Dr. Koo received his M.D. degree from Harvard Medical School, Boston, Massachusetts, USA. Dr. Koo has been named on the list, “Best Doctors in America.” Dr. Koo is Board Certified in Psychiatry and Dermatology.
- Chai Sue Lee, Director of the Psoriasis and Phototherapy Treatment Center in the Department of Dermatology, University of California Davis Medical Center, Sacramento, California, USA. Dr. Lee received her M.S. and M.D. degrees from the University of California, San Francisco, and the University of California, Berkeley Joint Degree Program, Berkeley, California, USA.
- Mark G. Lebwohl, Professor of Dermatology and Chairman of the Department of Dermatology, the Mount Sinai School of Medicine, New York, New York, USA, and Chairman of the Medical Board of the National Psoriasis Foundation. Dr. Lebwohl received his M.D. from Harvard Medical School, Boston, Massachusetts, USA. Dr. Lebwohl is the founding editor of Psoriasis Forum and is on the editorial board of the Journal of the American Academy of Dermatology.
